세계의 에피제네틱스 시장 규모 : 제품 유형별, 용도별, 최종사용자별, 지역별, 범위 및 예측

Epigenetics Market Size And Forecast

Epigenetics Market size was valued at USD 1.30 Billion in 2024 and is projected to reach USD 3.70 Billion by 2031 , growing at a CAGR of 13.94% from 2024 to 2031. Epigenetics is the study of heritable changes in gene expression that do not entail modifications to the underlying DNA sequence. These alterations can occur through a variety of methods, including DNA methylation, histone modification, and non-coding RNA molecules, all of which can influence gene function and contribute to phenotypic variability. Epigenetics is important in many biological processes, including development, cellular differentiation, and reactions to environmental stimuli. Epigenetics is finding new applications in sectors such as cancer research, where understanding epigenetic modifications might lead to novel therapeutic methods, and personalized medicine, where epigenetic profiling can guide treatment strategies.

Epigenetics is set for considerable progress, particularly with the incorporation of cutting-edge technologies like CRISPR gene editing and high-throughput sequencing. These advancements will improve our grasp of the epigenetic landscape and its dynamic character, allowing researchers to unravel complicated disorders on a molecular scale.

Epigenetic therapies, which aim to repair aberrant epigenetic alterations, offer intriguing treatment options for a variety of ailments, including neurological disorders and metabolic diseases. As our understanding of epigenetics grows, it is expected to play an increasingly important role in developing healthcare and therapeutic interventions, paving the path for more tailored and successful treatments.

Global Epigenetics Market Dynamics

The key market dynamics that are shaping the global epigenetics market include:

Key Market Drivers:

Increasing Cancer Prevalence:

The increased global prevalence of cancer is a significant driver of the epigenetics market. According to the WHO, cancer killed roughly 10 million people in 2020, and the IARC projects 28.4 million new cases by 2040, a 47% rise. The increase in cancer incidence is driving up demand for epigenetic medicines and diagnostics, as researchers seek more effective, targeted treatments based on gene expression variations.

Rising Investment in Research and Development:

Increased funding for epigenetic research is driving market expansion. According to the National Institutes of Health (NIH), funding for epigenetics research has surged by 85% over the past decade, from $573 million in 2013 to $1.06 billion in 2022. This significant funding has accelerated the development of epigenetic-based medicines and diagnostic tools.

Growing Application in Personalized Medicine:

The epigenetics market is experiencing growth due to the trend towards personalized medicine. The tailored Medicine Coalition reported that tailored medicines accounted for 25% of all new pharmaceuticals approved by the FDA in 2018, up from 5% in 2005. Epigenetic biomarkers are critical for personalizing treatments to individual patients, which drives demand for epigenetic technology and services.

Key Challenges:

Complexity of Epigenetic Mechanisms:

Epigenetic regulation involves a variety of mechanisms, including DNA methylation, histone modification, and RNA interference, all of which interact intimately. Understanding these complicated systems is difficult, delaying the development of targeted medicines. The necessity to determine the precise function of various systems in diseases hampers research, affecting the rate at which new medicines are found and commercialized.

High Research and Development Costs:

Developing epigenetic-based medicines and diagnostics necessitates advanced technology and knowledge, which raises R&D costs. The high expense of cutting-edge sequencing technologies, bioinformatics tools, and clinical trials places a financial burden on smaller biotech enterprises. As a result, innovation is restricted to well-funded institutions, delaying market expansion and preventing the entry of new firms.

High Failure Rate in Clinical Trials:

Many epigenetic medicines fail to show efficacy or safety in clinical trials, owing to significant attrition rates. These failures not only discourage investment but also raise expenses and slow the approval of potential medicines. The high failure rate reflects the complexities of converting epigenetic pathways into practical medicines, which has slowed market advancement.

Key Trends:

Advancements in Sequencing Technologies:

Next-generation sequencing (NGS) technologies have considerably increased the ability to examine epigenetic changes at the genome-wide level. These developments enable more precise detection of DNA methylation and histone changes, resulting in faster and more accurate research. The lower cost and better efficiency of NGS are driving the development of tailored medicines based on an individual's epigenetic profile, hastening the growth of the epigenetics market.

Growing Focus on Personalized Medicine:

Epigenetics is an important component of personalized medicine as it allows for therapies that are matched to individual genetic and epigenetic profiles. Personalized epigenetic therapy can target specific gene expression alterations associated with diseases such as cancer, increasing treatment efficacy while lowering negative effects. As the healthcare industry shifts toward more personalized treatment, demand for epigenetic diagnostics and medicines is increasing.

Growing Interest in Aging and Epigenetics:

Epigenetics has grown increasingly important in aging research, with studies indicating that age-related changes in gene expression contribute to a variety of diseases, including cancer and neurological disorders. As the world's population ages, there is a rising emphasis on understanding how epigenetic modifications affect aging processes and how medicines may be able to slow or reverse these changes, generating market interest and investment.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Epigenetics Market Regional Analysis

Here is a more detailed regional analysis of the global epigenetics market:

North America:

North America continues to dominate the global epigenetics market, owing to considerable research investments and a high prevalence of epigenetic illnesses, particularly cancer. The NIH's funding for epigenetics research in the US has increased by 85%, from $573 million in 2013 to $1.06 billion in 2022. This initiative demonstrates the region's commitment to advancing epigenetic medicines and diagnostics. With roughly 2 million new cancer cases projected in the United States by 2023, demand for epigenetic-based treatments is increasing, as epigenetic modifications play an important role in cancer formation.

The region's robust biotechnology and pharmaceutical industries also drive innovation. In 2018, the US bioscience industry employed 1.87 million workers, allowing for the quick commercialization of epigenetic discoveries. The FDA's approval of many epigenetic treatments contributes to market growth. North America's early embrace of advanced technology such as next-generation sequencing, hastens epigenetics research and ensures its market dominance.

Asia Pacific:

The Asia Pacific epigenetics market is expanding rapidly, fueled by increased research funding and the rising prevalence of diseases with epigenetic connections, such as cancer. Regional R&D spending is expected to exceed $1.2 trillion by 2025, with a major amount dedicated to life sciences and biotechnology. Countries like China, which are predicted to see a huge increase in cancer incidence (from 4.57 million in 2020 to 6.67 million by 2040), are driving demand for epigenetic-based diagnostics and cures. This increase in investment and illness load is hastening the region's market expansion.

Furthermore, aging populations, notably in Japan, and supportive government programs, such as India's Genome India Project, are accelerating epigenetics research. Rising disposable income in the region, which has resulted in higher healthcare spending, is pushing up demand for innovative medical technologies such as epigenetic tools. The increased usage of next-generation sequencing technology, projected to reach $5.6 billion by 2026, is permitting more complex epigenetic investigations, establishing Asia Pacific as a significant player in the global epigenetics market.

Global Epigenetics Market: Segmentation Analysis

The Global Epigenetics Market is Segmented on the basis of Product Type, Application, End-User, And Geography.

Epigenetics Market, By Product Type

• Kits and Reagents
• Instruments and Equipment
• Enzymes

Based on Product Type, the market is bifurcated into Kits and Reagents, Instruments and Equipment, and Enzymes. The Kits and Reagents category is dominant due to their essential significance in research and diagnosis, since they are commonly employed for DNA methylation, histone modification, and chromatin accessibility studies. The fastest-growing area is Enzymes, which is being driven by rising demand for enzymes such as DNA methyltransferases and histone deacetylases in drug discovery and personalized medicine, particularly in cancer research and therapeutic development.

Epigenetics Market, By Application

• Oncology
• Neurology
• Developmental Biology

Based on Application, the market is segmented into Oncology, Neurology, and Developmental Biology. Oncology is the dominant segment, owing to the high frequency of cancer and the crucial significance of epigenetic changes in cancer genesis, diagnosis, and treatment. Epigenetic treatments, which target DNA methylation and histone modification, are commonly used in oncology. Neurology is the fastest-growing category, with research into epigenetic aspects in neurodegenerative disorders such as Alzheimer's and Parkinson's gaining traction, opening up new diagnostic and therapeutic possibilities.

Epigenetics Market, By End-User

• Academic Research
• Pharmaceutical and Biotechnology Companies
• Clinical Laboratories
• Government Research Institutes

Based on End-User, the market is segmented into Academic Research, Pharmaceutical and Biotechnology Companies, Clinical Laboratories, and Government Research Institutes. Pharmaceuticals and Biotechnology Companies dominate due to their essential role in creating epigenetic-based medicines, particularly for cancer and other chronic diseases. These companies make significant investments in research and development to create novel medications and diagnostic technologies. Academic Research is the fastest-growing category, driven by rising funding for fundamental and translational epigenetics research as universities and research institutes investigate new therapeutic targets and personalized medicine applications.

Epigenetics Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World
• On the basis of geographical analysis, the Global Epigenetics Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America has been the dominating region in the epigenetics market due to its strong research infrastructure, the presence of large firms, and the well-developed regulatory environment. The Asia Pacific region is witnessing the quickest development, owing to increased research spending, increased knowledge of epigenetics, favorable government regulations, and rising disposable income.

Key Players

• The "Global Epigenetics Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Shutterstock, Inc., Adobe Inc., Getty Images, Inc., Pond5, Inc., iStock (by Getty Images), VideoBlocks, Storyblocks, Inc., Dissolve, Inc., Depositphotos, Inc., and MotionElements Pte. Ltd.
• The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Epigenetics Market Recent Developments
• In January 2024, Moonwalk Biosciences, a pioneering genomic medicine startup focused on the creation of precise epigenetic therapeutics, raised USD 57 million in seed and Series A funding. Alpha Wave Ventures, ARCH Venture Partners, Future Ventures, GV, Khosla Ventures, and YK Bioventures were among the major investors who donated investments.
• In February 2024, PharmaKure, a clinical-stage pharmaceutical company, announced a new epigenetics relationship with Sheffield Hallam University. This partnership will focus on 'gene-based environmental biomarkers,' also known as epigenetic markers, to estimate risk scores for Alzheimer's disease.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Epigenetics Market, By Product Type

• Kits and Reagents
• Instruments and Equipment
• Services and Software

5. Epigenetics Market, By Application

• Oncology
• Neurology
• Heart Disease
• Developmental Biology

6. Epigenetics Market, By End-User

• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Clinical Laboratories
• Agri-Biotech Companies

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Shutterstock, Inc.
• Adobe Inc.
• Getty Images, Inc.
• Pond5, Inc.
• iStock (by Getty Images)
• VideoBlocks
• Storyblocks, Inc.
• Dissolve, Inc.
• Depositphotos, Inc.
• MotionElements Pte. Ltd.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References